4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Fei Chang, Na Li, Kang Yan, Yumin Huang, Hongfei Xu, Yongjian Liu. Luminal/extracellular domains of chimeric CI-M6PR-C proteins interfere with their retrograde endosome-to-TGN trafficking in the transient expression system[J]. The Journal of Biomedical Research, 2018, 32(4): 245-256. DOI: 10.7555/JBR.32.20180044
Citation: Fei Chang, Na Li, Kang Yan, Yumin Huang, Hongfei Xu, Yongjian Liu. Luminal/extracellular domains of chimeric CI-M6PR-C proteins interfere with their retrograde endosome-to-TGN trafficking in the transient expression system[J]. The Journal of Biomedical Research, 2018, 32(4): 245-256. DOI: 10.7555/JBR.32.20180044

Luminal/extracellular domains of chimeric CI-M6PR-C proteins interfere with their retrograde endosome-to-TGN trafficking in the transient expression system

Funds: 

This work was supported by the National Nature Science Foundation of China to Y. Liu (Grant No. 31371436 and No. 8157051134) and to Y. Huang (Grant No. 81500678), and the laboratory start-up grant from Nanjing Medical University to Y. Liu. We thank Dr. Richard G. MacDonald (University of Nebraska Medical Center, USA) and Dr. Tuanlao Wang (Xiamen 254 Chang F et al. J Biomed Res, 2018, 32(4)University, China) for kindly providing plasmids containing full-length cDNA of human Myc-CI-M6PR and CD8, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript

More Information
  • Received Date: March 02, 2018
  • Revised Date: May 07, 2018
  • The membrane trafficking of cation-independent mannose 6-phosphate receptor (CI-M6PR) between the transGolgi network (TGN) and endosomal compartments is not only critical for maintaining lysosomal function but also a well-known event for understanding molecular and cellular mechanisms in retrograde endosome-to-TGN trafficking. Although it has been well established in literature that the C-terminus of bovine CI-M6PR determines its retrograde trafficking, it remains unclear whether the luminal domain of the protein plays a role on these sorting events. In this study, we found that partial deletion of luminal domain of human CI-M6PR mistargeted the mutant protein to nonTGN compartments. Moreover, replacing the luminal domain of both bovine and human CI-M6PR with that from irrelevant membrane proteins such as CD8 or Tac also altered the TGN targeting of the chimeric proteins. On the other hand, only short sequence from HA fused with the transmembrane domain and C-terminus of the receptor, HA-hCIM6PR-tail, resulted in its preferential targeting to TGN as for the full length receptor, strongly suggesting that sorting of the receptor may be influenced by luminal sequence. Furthermore, using this luminal truncated form of HA-hCIM6PR as a model cargo, we found that the trafficking of the chimeric protein was regulated by the retromer complex through interacting with SNX5. In conclusion, our study strongly suggested that the disrupted luminal domain from hCI-M6PR or other irrelevant membrane proteins interfere with the process of membrane trafficking and TGN targeting of CI-M6PR.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Vitaly Chasov, Damir Davletshin, Elvina Gilyazova, Regina Mirgayazova, Anna Kudriaeva, Raniya Khadiullina, Youyong Yuan, Emil Bulatov. Anticancer therapeutic strategies for targeting mutant p53-Y220C[J]. The Journal of Biomedical Research, 2024, 38(3): 222-232. DOI: 10.7555/JBR.37.20230093
    [3]Qing Chen, Meiheng Sun, Xu Han, Hongfei Xu, Yongjian Liu. Structural determinants specific for retromer protein sorting nexin 5 in regulating subcellular retrograde membrane trafficking[J]. The Journal of Biomedical Research, 2023, 37(6): 492-506. DOI: 10.7555/JBR.37.20230112
    [4]Minqin Xu, Lihua Zhang, Lan Lin, Zhiyi Qiang, Wei Liu, Jian Yang. Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1[J]. The Journal of Biomedical Research, 2023, 37(6): 431-447. DOI: 10.7555/JBR.37.20230047
    [5]Xiaochen Huang, Jiaojiao Guo, Tao Li, Lizhou Jia, Xiaojun Tang, Jin Zhu, Qi Tang, Zhenqing Feng. c-Met-targeted chimeric antigen receptor T cells inhibit hepatocellular carcinoma cells in vitro and in vivo[J]. The Journal of Biomedical Research, 2022, 36(1): 10-21. DOI: 10.7555/JBR.35.20200207
    [6]Adittya Arefin, Tanzila Ismail Ema, Tamnia Islam, Md. Saddam Hossen, Tariqul Islam, Salauddin Al Azad, Md. Nasir Uddin Badal, Md. Aminul Islam, Partha Biswas, Nafee Ul Alam, Enayetul Islam, Maliha Anjum, Afsana Masud, Md. Shaikh Kamran, Ahsab Rahman, Parag Kumar Paul. Target specificity of selective bioactive compounds in blocking α-dystroglycan receptor to suppress Lassa virus infection: an in silico approach[J]. The Journal of Biomedical Research, 2021, 35(6): 459-473. DOI: 10.7555/JBR.35.20210111
    [7]Sun Meihen, Han Xu, Chang Fei, Xu Hongfei, Colgan Lesley, Liu Yongjian. Regulatory role of sorting nexin 5 in protein stability and vesicular targeting of vesicular acetylcholine transporter to synaptic vesicle-like vesicles in PC12 cells[J]. The Journal of Biomedical Research, 2021, 35(5): 339-350. DOI: 10.7555/JBR.34.20200095
    [8]Min Feng, Xin Hu, Na Li, Fan Hu, Fei Chang, Hongfei Xu, Yongjian Liu. Distinctive roles of Rac1 and Rab29 in LRRK2 mediated membrane trafficking and neurite outgrowth[J]. The Journal of Biomedical Research, 2018, 32(2): 145-156. DOI: 10.7555/JBR.31.20170039
    [9]Qiuzi Wu, Hongfei Xu, Wei Wang, Fei Chang, Yu Jiang, Yongjian Liu. Retrograde trafficking of VMAT2 and its role in protein stability in non-neuronal cells[J]. The Journal of Biomedical Research, 2016, 30(6): 502-509. DOI: 10.7555/JBR.30.20160061
    [10]Oluyomi S. Adeyemi, Faoziyat A. Sulaiman. Evaluation of metal nanoparticles for drug delivery systems[J]. The Journal of Biomedical Research, 2015, 29(2): 145-149. DOI: 10.7555/JBR.28.20130096

Catalog

    Article Metrics

    Article views (3758) PDF downloads (177) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return